Adalimumab and infliximab of use inflammatory markers, cytokines and matrix metalloproteinase-3 levels effect in patient with rheumatoid arthritis and ankylosing spondylitis

Saved in:
Bibliographic Details
Published in:Şişli Etfal Hastanesi tıp bülteni 2015-03, p.18-24
Main Authors: Serin, Sibel, Okuturlar, Yıldız, Gözkaman, Ayşe, Coşkun, Belkıs Nihan, Yağız, Vehbi, Dilek, Kamil
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 24
container_issue
container_start_page 18
container_title Şişli Etfal Hastanesi tıp bülteni
container_volume
creator Serin, Sibel
Okuturlar, Yıldız
Gözkaman, Ayşe
Coşkun, Belkıs Nihan
Yağız, Vehbi
Dilek, Kamil
description
doi_str_mv 10.5350/SEMB.20141014064600
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_5350_SEMB_20141014064600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_5350_SEMB_20141014064600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c890-8127571cd5cf96b666afbe04a106bd032532245e045274d25be30dd8488c7c653</originalsourceid><addsrcrecordid>eNpVkEtOwzAQhi0EElXpCdj4AKT4ETvpslTlIRWxoPvIiR1q6tiR7UJzKO6I07JhpNH8M6P5pfkAuMVozihD9-_r14c5QTjHKRHPOUIXYIIpKjOGCb08aZIVSV-DWQifKAXHpMjLCfhZSmF0d-hEDYWVUNvW6KMeW9fCQ1Cnieg6EZ0fYCf8XvlwB5shur22Kpyu0tbrI-xUFMa43ruotBVBZRQa9aVMgKptVROTGexF1MpG-K3jDvqdOozWWkLh487rqM-Owu4H44K2HzD0zsrBjKsbcNUKE9Tsr07B9nG9XT1nm7enl9VykzXlAmVl-o0VuJGsaRe85pyLtlYoFxjxWiJKGCUkZ2nCEgRJWK0okrLMy7IpGs7oFNCzbeNdCF61Ve8TEj9UGFUj82pkXv1nTn8BiUx5Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Adalimumab and infliximab of use inflammatory markers, cytokines and matrix metalloproteinase-3 levels effect in patient with rheumatoid arthritis and ankylosing spondylitis</title><source>Publicly Available Content Database</source><creator>Serin, Sibel ; Okuturlar, Yıldız ; Gözkaman, Ayşe ; Coşkun, Belkıs Nihan ; Yağız, Vehbi ; Dilek, Kamil</creator><creatorcontrib>Serin, Sibel ; Okuturlar, Yıldız ; Gözkaman, Ayşe ; Coşkun, Belkıs Nihan ; Yağız, Vehbi ; Dilek, Kamil</creatorcontrib><identifier>ISSN: 1302-7123</identifier><identifier>EISSN: 1308-5123</identifier><identifier>DOI: 10.5350/SEMB.20141014064600</identifier><language>eng</language><ispartof>Şişli Etfal Hastanesi tıp bülteni, 2015-03, p.18-24</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Serin, Sibel</creatorcontrib><creatorcontrib>Okuturlar, Yıldız</creatorcontrib><creatorcontrib>Gözkaman, Ayşe</creatorcontrib><creatorcontrib>Coşkun, Belkıs Nihan</creatorcontrib><creatorcontrib>Yağız, Vehbi</creatorcontrib><creatorcontrib>Dilek, Kamil</creatorcontrib><title>Adalimumab and infliximab of use inflammatory markers, cytokines and matrix metalloproteinase-3 levels effect in patient with rheumatoid arthritis and ankylosing spondylitis</title><title>Şişli Etfal Hastanesi tıp bülteni</title><issn>1302-7123</issn><issn>1308-5123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkEtOwzAQhi0EElXpCdj4AKT4ETvpslTlIRWxoPvIiR1q6tiR7UJzKO6I07JhpNH8M6P5pfkAuMVozihD9-_r14c5QTjHKRHPOUIXYIIpKjOGCb08aZIVSV-DWQifKAXHpMjLCfhZSmF0d-hEDYWVUNvW6KMeW9fCQ1Cnieg6EZ0fYCf8XvlwB5shur22Kpyu0tbrI-xUFMa43ruotBVBZRQa9aVMgKptVROTGexF1MpG-K3jDvqdOozWWkLh487rqM-Owu4H44K2HzD0zsrBjKsbcNUKE9Tsr07B9nG9XT1nm7enl9VykzXlAmVl-o0VuJGsaRe85pyLtlYoFxjxWiJKGCUkZ2nCEgRJWK0okrLMy7IpGs7oFNCzbeNdCF61Ve8TEj9UGFUj82pkXv1nTn8BiUx5Rg</recordid><startdate>20150326</startdate><enddate>20150326</enddate><creator>Serin, Sibel</creator><creator>Okuturlar, Yıldız</creator><creator>Gözkaman, Ayşe</creator><creator>Coşkun, Belkıs Nihan</creator><creator>Yağız, Vehbi</creator><creator>Dilek, Kamil</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20150326</creationdate><title>Adalimumab and infliximab of use inflammatory markers, cytokines and matrix metalloproteinase-3 levels effect in patient with rheumatoid arthritis and ankylosing spondylitis</title><author>Serin, Sibel ; Okuturlar, Yıldız ; Gözkaman, Ayşe ; Coşkun, Belkıs Nihan ; Yağız, Vehbi ; Dilek, Kamil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c890-8127571cd5cf96b666afbe04a106bd032532245e045274d25be30dd8488c7c653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serin, Sibel</creatorcontrib><creatorcontrib>Okuturlar, Yıldız</creatorcontrib><creatorcontrib>Gözkaman, Ayşe</creatorcontrib><creatorcontrib>Coşkun, Belkıs Nihan</creatorcontrib><creatorcontrib>Yağız, Vehbi</creatorcontrib><creatorcontrib>Dilek, Kamil</creatorcontrib><collection>CrossRef</collection><jtitle>Şişli Etfal Hastanesi tıp bülteni</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serin, Sibel</au><au>Okuturlar, Yıldız</au><au>Gözkaman, Ayşe</au><au>Coşkun, Belkıs Nihan</au><au>Yağız, Vehbi</au><au>Dilek, Kamil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adalimumab and infliximab of use inflammatory markers, cytokines and matrix metalloproteinase-3 levels effect in patient with rheumatoid arthritis and ankylosing spondylitis</atitle><jtitle>Şişli Etfal Hastanesi tıp bülteni</jtitle><date>2015-03-26</date><risdate>2015</risdate><spage>18</spage><epage>24</epage><pages>18-24</pages><issn>1302-7123</issn><eissn>1308-5123</eissn><doi>10.5350/SEMB.20141014064600</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1302-7123
ispartof Şişli Etfal Hastanesi tıp bülteni, 2015-03, p.18-24
issn 1302-7123
1308-5123
language eng
recordid cdi_crossref_primary_10_5350_SEMB_20141014064600
source Publicly Available Content Database
title Adalimumab and infliximab of use inflammatory markers, cytokines and matrix metalloproteinase-3 levels effect in patient with rheumatoid arthritis and ankylosing spondylitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T13%3A07%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adalimumab%20and%20infliximab%20of%20use%20inflammatory%20markers,%20cytokines%20and%20matrix%20metalloproteinase-3%20levels%20effect%20in%20patient%20with%20rheumatoid%20arthritis%20and%20ankylosing%20spondylitis&rft.jtitle=%C5%9Ei%C5%9Fli%20Etfal%20Hastanesi%20t%C4%B1p%20b%C3%BClteni&rft.au=Serin,%20Sibel&rft.date=2015-03-26&rft.spage=18&rft.epage=24&rft.pages=18-24&rft.issn=1302-7123&rft.eissn=1308-5123&rft_id=info:doi/10.5350/SEMB.20141014064600&rft_dat=%3Ccrossref%3E10_5350_SEMB_20141014064600%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c890-8127571cd5cf96b666afbe04a106bd032532245e045274d25be30dd8488c7c653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true